202 related articles for article (PubMed ID: 26324296)
21. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
[TBL] [Abstract][Full Text] [Related]
22. Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4).
Cizmecioglu O; Krause A; Bahtz R; Ehret L; Malek N; Hoffmann I
J Cell Sci; 2012 Feb; 125(Pt 4):981-92. PubMed ID: 22399798
[TBL] [Abstract][Full Text] [Related]
23. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
24. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
[TBL] [Abstract][Full Text] [Related]
25. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M
Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118
[TBL] [Abstract][Full Text] [Related]
26. Fbxw7 controls angiogenesis by regulating endothelial Notch activity.
Izumi N; Helker C; Ehling M; Behrens A; Herzog W; Adams RH
PLoS One; 2012; 7(7):e41116. PubMed ID: 22848434
[TBL] [Abstract][Full Text] [Related]
27. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
[TBL] [Abstract][Full Text] [Related]
28. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
29. LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation.
Zhang P; Cao L; Fan P; Mei Y; Wu M
EMBO Rep; 2016 Aug; 17(8):1204-20. PubMed ID: 27317567
[TBL] [Abstract][Full Text] [Related]
30. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.
Zhang MX; Wang H; Sun GP
Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091
[TBL] [Abstract][Full Text] [Related]
31. Increased efficiency in the generation of induced pluripotent stem cells by Fbxw7 ablation.
Okita Y; Matsumoto A; Yumimoto K; Isoshita R; Nakayama KI
Genes Cells; 2012 Sep; 17(9):768-77. PubMed ID: 22897623
[TBL] [Abstract][Full Text] [Related]
32. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
[TBL] [Abstract][Full Text] [Related]
33. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
[TBL] [Abstract][Full Text] [Related]
34. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
[TBL] [Abstract][Full Text] [Related]
35. Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue.
Imura S; Tovuu LO; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Yamada S; Ishikawa D; Bando Y; Shimada M
J Gastroenterol Hepatol; 2014 Oct; 29(10):1822-9. PubMed ID: 24731221
[TBL] [Abstract][Full Text] [Related]
36. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.
Cao J; Ge MH; Ling ZQ
Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596
[TBL] [Abstract][Full Text] [Related]
37. Skp1-Cullin-F-box (SCF)-type ubiquitin ligase FBXW7 negatively regulates spermatogonial stem cell self-renewal.
Kanatsu-Shinohara M; Onoyama I; Nakayama KI; Shinohara T
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8826-31. PubMed ID: 24879440
[TBL] [Abstract][Full Text] [Related]
38. Emerging roles for the FBXW7 ubiquitin ligase in leukemia and beyond.
Kourtis N; Strikoudis A; Aifantis I
Curr Opin Cell Biol; 2015 Dec; 37():28-34. PubMed ID: 26426760
[TBL] [Abstract][Full Text] [Related]
39. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.
Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S
Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148
[TBL] [Abstract][Full Text] [Related]
40. CRL2
Motomura S; Yumimoto K; Tomonaga T; Nakayama KI
Oncogene; 2024 Jun; 43(25):1917-1929. PubMed ID: 38698266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
